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Abstract
Although the pro-adipogenic effect of glucocorticoid (GC) on adipose tissue (AT) precursor cell differentiation is openly accepted, the effect of
chronically high peripheral levels of GC on AT mass expansion is not fully understood. In the present study, we aim to assess the in vitro adipo-
genic capacity of AT precursor cells isolated from retroperitoneal (RP) AT pads of the hypercorticosteronaemic, adult neonatally treated mono-
sodium L-glutamate (MSG) male rat. To ascertain this issue, we explored the in vitro adipogenic process of stromal-vascular fraction (SVF)
cells isolated from RPAT pads of 60-day-old MSG rats. The data recorded indicated that RPAT-SVF cells from hypercorticosteronaemic MSG
rats, although displaying an enhanced proliferation capacity, differentiated slower than normal cells. This dysfunction was associated with a
reduction in key parameters indicative of precursor cell commitment, differentiation capacity and the percentage of fully differentiated adipo-
cytes, with a retarded maturation process. The distorted adipogenic capacity was highly conditioned by RPAT-SVF cells displaying a low com-
mitted population and both excessive and reduced expression of anti- (Pref-1 and Wnt-10b) and pro-adipogenic (mineralocorticoid receptor)
signals respectively. Notably, the normalization of peripheral corticosterone levels in MSG rats, as a result of bilateral adrenalectomy combined
with GC replacement therapy, fully prevented reduced RPAT precursor cell commitment and overall impaired adipogenesis. Our study strongly
supports that the impaired adipogenic process observed in the adult hypertrophic obese MSG male rat is a GC-dependent mechanism, thus
explaining the unhealthy RPAT expansion observed in human hypertrophic obese phenotypes, such as in the Cushing’s syndrome.
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Introduction
Adipogenesis is a highly ordered temporal sequence of events occur-
ring at the adipose tissue (AT) precursor cell level. AT committed
cells – Zfp423 and peroxisome proliferator-activated receptor
(PPAR)-c2-positive cells [1] – undergo terminal differentiation, which
includes: (a) activation of the pivotal pro-adipogenic cell structure,
mineralocorticoid receptor (MR) [2], (b) reduction in the cell expres-
sion of anti-adipogenic signals [e.g. pre-adipocyte factor-1 (Pref-1)
and wingless-type MMTV integration site family, member 10b (Wnt-
10b)] [3] and (c) increase in the cell expression of pro-adipogenic
factors [e.g. PPAR-c2, CBEP/a] [4]. The adipogenic process can be
reproduced in vitro mainly by stimulating MR [2] in AT stromal-vas-
cular fraction (SVF)-committed cells with dexamethasone (DXM) and
insulin [5].
It has been reported that rats treated with monosodium L-gluta-
mate (MSG) at neonatal age develop hyperadiposity [6] and neuroen-
docrine dysfunctions [7]. It is true that the adult MSG rat shares
several characteristics with the human phenotypes of hypertrophic
obesity, namely that of the Cushing’s syndrome. Among them are hy-
perleptinaemia [8], increased visceral AT (VAT) mass and cell size [9,
10], and excessive production of glucocorticoid (GC) [11, 12]. MSG
treatment damages hypothalamic arcuate nucleus (ARC) neurons [7]
in charge of energy homeostasis control. Consequently, the cross-talk
between hypothalamo-pituitary-adrenal (HPA) axis and AT functions
[11, 12] becomes disrupted. In fact, an early development of
enhanced adrenal GC production [10, 11] increased leptinaemia [13];
thus, these rats develop adrenal leptin-resistance [11, 13]. Thereafter,
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a worsening in the metabolism of the adult MSG rat is because of the
development of hyperinsulinaemia [8, 14] and reduced catecholamine
production [15]. As a result, VAT adipocytes of MSG rats became
hypertrophic, insulin resistant and over-produce both leptin [8] and
lipids [16]. In turn, hyperlipidaemia [17] and ectopic lipid deposition
[18] aggravate this phenotype.
We earlier reported that several metabolic-neuroendocrine dys-
functions of the MSG rat are dependent on enhanced GC production
[8, 11, 14]. Because most of the obesity-associated metabolic disor-
ders are dependent on VAT dysfunction, the aim was to explore in the
adult MSG rat whether: (a) the endogenous GC-rich milieu could
impact on the ex vivo adipogenic capacity of retroperitoneal AT
(RPAT) SVF cells; and (b) the normalization of corticoadrenal hyper-
activity could be crucial for further amelioration of unhealthy AT
expansion.
Materials and methods
Animals
Male newborn Sprague–Dawley rats were injected i.p with either 4 mg/g
BW MSG (Sigma Chemical CO., St. Louis, MO, USA; dissolved in sterile
0.9% NaCl) or 10% NaCl (litter-mate controls; CTR) on alternate days
between 2 and 10 days of age [14]. Weaned rats (21 days of age) were
individually caged and kept in a light (lights on between 7 a.m. and
7 p.m.)- and temperature (22°C)-controlled room; rat Purina chow (Gan-
ave, Argentina) and water were available ad libitum until experimentation
(age 60 days). MSG-injected animals were screened for effectiveness of
treatment by: hypophagia, decreased hypothalamic NPY mRNA expres-
sion and macroscopic observation of degeneration of the optic nerves at
the time of sacrifice [14]. In each experiment, CTR and MSG rats were
members of the same litters; however, when accumulating experiments,
each different experiment was performed with animals from different
litters. Animals were killed by decapitation in non-fasting condition
(8–9 a.m.), and trunk blood was collected into EDTA-coated tubes. Tubes
were rapidly centrifuged (4°C; 2500 9 g; 15 min.) and plasma samples
kept frozen (20°C) until metabolite measurements. We have chosen the
RPAT pad for the reason that is a non-visceral fat pad, closely related for
paracrine interaction with adrenal corticosteroids, and with a single vagal
innervation. Our Institutional Animal Care Committee approved all experi-
ments. Animal manipulation followed protocols for animal use, in agree-
ment with NIH Guidelines for care and use of experimental animals.
Experimental designs
Experiment 1
RPAT pads from CTR and MSG rats were aseptically dissected, weighed
and placed in sterile Petri dishes containing 10 ml of sterile DMEM med-
ium. Pads were then used in several experiments, as described below.
Morphometric studies in RPAT pads. Freshly dissected AT pads were
immediately fixed in 4% paraformaldehyde (in 0.2 M phosphate buffer),
at 4°C for a maximum of 3 days. Tissues were then washed with
0.01 M PBS and immersed in 70% ethanol for 24 hrs before being
processed and embedded in paraffin. Sections of 4 lm were obtained
at different levels of the blocks and stained with haematoxylin–eosin,
then examined with a Jenamed 2 Carl Zeiss light microscope; quantita-
tive morphometric analysis was performed with a RGB CCD Sony
camera together with the OPTIMAS software (Bioscan Incorporated, Ed-
mons, WA, USA; 409 objective). For each RPAT sample (n = 4/5 ani-
mals per group), systematic random sampling was used to select 10
fields for each section and a minimum of 100 cells per group were
examined. Each field of cells in a reference area (RA: tissue area
scanned where adipocytes were scored) was measured for an average
of 10 micrographs taken from two different levels. These measurements
were recorded and processed, and two parameters were then calcu-
lated: cell density (CD: number of adipocytes/RA) and cell size (CS;
expressed in lm2) [8].
RPAT-SVF cell isolation and proliferation. Pads were processed as previ-
ously described [19]. Briefly, pads were minced and digested using 1 mg/
ml collagenase solution in DMEM (37°C–1 hr). After centrifugation
(280 9 g, 15 min.), floating adipocytes were discarded and the SVF cell-
pellet was collected, filtered (in a 50-lm mesh nylon cloth) and washed
(92) with DMEM. Isolated SVF cells were then seeded (density: 15,000
cells/well; 24-well plates) and cultured in DMEM supplemented with HEPES
(20 nM), 10% (vol/vol) foetal bovine serum (FBS), 100 U/ml penicillin and
100 lg/ml streptomycin at 37°C in a 5% CO2-atmosphere. Cells were left
in culture to proliferate up to 9 days (Proliferation day: Pd 9). Every 24 hrs,
cells (4 wells per day) were washed (91) with PBS buffer. Thereafter, a
0.25% (w/v) trypsin solution (dissolved in PBS-EDTA) was added for 2–
3 min. at 37°C; cell suspension was then collected and cell number was
determined in a Newbauer chamber.
Adipogenic and inflammatory markers in RPAT-SVF cells. Precursor
cells were obtained from CTR and MSG RPAT pads as described above.
Thereafter, total RNA was isolated from cells by the single-step acid
guanidinium isothiocyanate-phenol-chloroform extraction method (Trizol;
Invitrogen, Life Tech., Waltham, MA, USA; cat. # 15596-026) [19]. It
was then proceeded to quantify cell mRNA expression levels of different
markers, such as: (a) those of AT precursor cell commitment (PPAR-c2
and Zfp423); (b) key pro-adipogenic factors (GR and MR); (c) pro-
inflammatory mediators (TNF-a, IL-6 and PAI-1); and (d) immune cell
recruitment (CD11b, F4/80 and MCP-1). One lg of total RNA was
reverse transcribed using random primers (250 ng) and Superscript III
Rnase HReverse Transcriptase (200 U/Hl; cat # 18989-093; Invitrogen,
Life Tech). Two lL of reverse transcription mix was amplified with
10 ll of QuantiTect SYBR green PCR solution kit (cat. # 204143; Qia-
gen, Waltham, MA, USA), in the presence of 1 ll of each specific pri-
mer (0.5 lM final concentration), and revealed using a LightCycler
Detection System (MJ Mini Opticon, Bio-Rad, Hercules, CA, USA). Spe-
cific primers used are shown in alphabetical order in Table 1, where b-
actin (ACTB) was the local reference gene marker. PCR efficiency was
near 1. Threshold cycles (Ct) were measured in separate tubes, by
duplicate. Identity and purity of the amplified product were checked by
electrophoresis on agarose mini-gels and the melting curve was analy-
sed at the end of amplification. The differences between Cts were calcu-
lated in every sample for each gene of interest as follows: Ct gene of
interestCt ACTB gene. Relative changes in the expression level of a spe-
cific gene (DDCt) were calculated as DCt of the test group minus DCt of
the CTR group, then expressed as 2DDCt.
RPAT-SVF cell differentiation. As previously reported [19], a similar
number of confluent (on Pd 5-6) SVF cells (100,000 cells, approxi-
mately) was induced to differentiate (Differentiation day zero; Dd 0) by
adding 5 lg/ml insulin, 0.25 lM DXM and 0.5 mM 3-isobutyl-L-methyl-
xanthine (IBMX) in DMEM-HEPES supplemented with 10% FBS and
antibiotics. After 48 hrs, media were removed and replaced by fresh
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media containing insulin (5 lg/ml), 10% FBS and antibiotics. Cells were
then kept in culture up to Dd 10 and media were replaced by fresh
media every 48 hrs. Media were stored at 20°C until measurement of
leptin (LEP) concentrations. Cell samples were harvested and processed
on different Dds for complementary determinations (see below).
Adipogenesis-related markers in
precursor cells undergoing differentiation
Intracellular cell lipid staining. Cells from Dd 0 throughout Dd 10 were
washed with PBS and fixed with 10% formalin (for 10–15 min.) in PBS.
Then, cells were quickly washed with isopropanol 60% and stained for
1 hr with Oil Red O solution (2:3 vol/vol H2O:isopropanol, containing
0.5% Oil Red O) [20]. After staining, cells were washed (93) with PBS,
and the dye from stained material was extracted by adding 200 ll of iso-
propanol (10 min.). To quantify cell lipid content, optical density (OD) of
samples was determined at 510 nm in a spectrophotometer. Remaining
cells were digested with 200 ll of 0.25% trypsin solution in PBS-EDTA
(37°C, 24 hrs). Thereafter, cell suspension was centrifuged at 8000 9 g
(15 sec.) and the OD of supernatants was read at 260 nm for DNA quan-
tification. Oil Red O absorbance values were standardized to reflect cul-
ture DNA.
Table 1 Rat specific primers (in alphabetical order) for real-time PCR analyses (se: sense; as: anti-sense; GBAN: GenBank Accession Number;
amplicon length, in bp)
GBAN bp
ACTB se, 50-AGCCATGTACGTAGCCATCC-30
as, 50-ACCCTCATAGATGGGCACAG-30
NM_031144 115
ADIPOQ se, 50-AATCCTGCCCAGTCATGAAG-30
as, 50-TCTCCAGGAGTGCCATCTCT-30
NM_144744 159
CD11b se, 50-CATCACCGTGAGTTCCACAC-30
as, 50-GAGAACTGGTTCTGGCTTGC-30
NM_012711.1 174
C/EBPa se, 50-CTGCGAGCACGAGACGTCTATAG-30
as, 50-TCCCGGGTAGTCAAAGTCACC-30
NM_012524 159
F 4/80 se, 50-CAGCTGTCTTCCCGACTTTC-30
as, 50-TAATCAAGATTCCGGCCTTG-30
NM_001007557.1 156
GR se, 50-TGCCCAGCATGCCGCTATCG-30
as, 50-GGGGTGAGCTGTGGTAATGCTGC-30
NW_047512 170
IL-6 se, 50-CTGATTGTATGAACAGCGATG-30
as, 50-GAACTCCAGAAGACCAGAGC-30
NM_012589.2 140
LEP se, 50-GAGACCTCCTCCATCTGCTG-30
as, 50-CTCAGCATTCAGGGCTAAGG-30
NM_013076 192
MCP-1 se, 50-TCCACATTCGGAGGCTAAAG-30
as, 50-ACGTGAAGGTTCAAGGATGC-30
NM_001105822.1 183
MR se, 50-TCGCTCCGACCAAGGAGCCA-30
as, 50- TTCGCTGCCAGGCGGTTGAG-30
NM_013131 193
PAI-1 se, 50-TGCCCCTCTCCGCCATCACC-30
as, 50-TCTCCAGGGGCCCTCTGAGGT-30
NM_012620.1 141
PPAR-c2 se, 50-AGGGGCCTGGACCTCTGCTG-30
as, 50-TCCGAAGTTGGTGGGCCAGA-30
NW_047696 185
Pref-1 se, 50-TGCTCCTGCTGGCTTTCGGC-30
as, 50-CCAGCCAGGCTCACACCTGC-30
NM_053744 113
TNFa se, 50-CATTCCTGCTCGTGGCGGGG-30
as, 50-CGACGTGGGCTACGGGCTTG-30
NM_012675.3 177
Wnt-10b se, 50-AGGGGCTGCACATCGCCGTTC-30
as, 50-ACTGCGTGCATGACACCAGCAG-30
NW_047784 175
Zfp423 se, 50-CCGCGATCGGTGAAAGTTG-30
as, 50-CACGGCTGGATTTCCGATCA-30
NM_053583.2 121
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Cell adipokine release. Media LEP concentrations (Dd 0-Dd 10) were
determined by a previously described radioimmunoassay (RIA) [8]. The
standard curve ranged between 50 and 12,500 pg/ml, and CVs intra-
and inter-assay were 4–6% and 5–8% respectively.
Cell adipogenesis gene-markers. Total RNA was isolated from cells
(harvested between Dd0 and Dd10) as described above. Thereafter,
mRNA expression levels of several markers of adipogenesis were deter-
mined by quantitative PCR as described before. For this aim, the follow-
ing factors were measured: adiponectin (ADIPOQ), C/EBP-a, LEP and
PPAR-c2; ACTB was used as a local reporter gene (details on these
specific primers are shown in Table 1).
Analysis of mature adipocytes. Separately, a similar number of conflu-
ent RPAT-SVF cells from different groups (on Pd 5-6) were cultured
(300,000 cells/well, approximately) on sterile cover glasses (in 6-well
plates) and induced to differentiate as described above. On Dd 10, cells
were fixed with 10% formalin solution for 1 hr at room temperature, and
then stained with haematoxylin–eosin. The percentage of differentiated
cells was calculated by counting the total number of cells and the number
of cells containing lipid droplets, when visualized in a light microscope
(after counting 200–250 total cells per cover glass, 409 magnification).
Lipid-containing cells were assigned to 3-graded stages of maturation
depending on the nucleus position [21], as: stage I (central), stage II
(between centre and periphery) and stage III (fully peripheral). The per-
centage of cells corresponding to each stage of maturation was expressed
in relation to the total number of differentiated cells. Image analysis was
assessed using a light microscope and image analysis software (Image
ProPlus 5.0, Rockville, MD, USA).
Experiment 2
Three weeks prior experimentation (day 39 of age), CTR and MSG
animals (n = 10/12 rats per group) were submitted (under light keta-
mine anaesthesia and by the dorsal approach) to either bilateral adre-
nalectomy (ADX) or sham-operation (SHX). At the time of surgery,
while MSG-ADX rats were sc implanted with 75 mg corticosterone
pellets (MSG-ADX+Cort), CTR-SHX and MSG-SHX animals were sc
implanted with placebo (P) pellets (CTR-SHX+P and MSG-SHX+P;
Innovative Research of America, Toledo, OH, USA) [14]. We earlier
established, as reported by the manufacturer, that ADX+Cort animals
Table 2 Bodyweight (BW), RPAT mass, peripheral levels of several
metabolites (n = 12/15 rats per group) and AAT cell expression
levels of pro-/anti-adipogenic genes (n = 4/5 different experiments,
4/5 replicates per experiment) in intact CTR and MSG male rats
CTR MSG
BW (g) 302.08  9.41 235.41  6.88*
RPAT Mass (g) 6.85  0.71 13.07  1.27*
RPAT Mass (g/100 g BW) 2.28  0.31 5.53  0.44*
Insulin (nM) 8.67  0.94 11.56  3.56
Leptin (ng/ml) 5.49  0.79 15.23  3.08*
TNF-a (pg/ml) 14.21  5.42 19.87  6.47
Corticosterone (nM) 7.79  1.58 35.86  7.01*
Aldosterone (pM) 95.25  25.58 90.03  21.97
Values are means  SEM.
*P < 0.05 or less versus CTR values.
A
B
D
C
Fig. 1 Representative fields of RPAT from
intact CTR (A) and MSG (B) rats. Adipo-
cytes, stained with haematoxylin–eosin,
they all show cytoplasmic rim of mature
adipocytes. Scale bar represents 50 lm.
Morphometric parameters of RPAT adipo-
cytes from intact CTR and MSG animals:
cell density (CD) (C) and cell size (CS)
(D). Values are the mean  SEM (n = 4/5
rats per group). *P < 0.01 versus CTR
values.
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display a constant peripheral level (5–6 lg/dl) of Cort [14]. Animals
were then returned to their home cages and MSG-ADX+Cort rats
drank NaCl 0.9% solution until experimentation. Following sacrifice,
RPAT pads were aseptically dissected and processed as described in
Experiment 1.
Peripheral metabolite measurements
Circulating levels of LEP, insulin and Cort were determined by specific
RIAs as earlier described [8]. Circulating concentrations of aldosterone
were measured using a commercial RIA kit (Diagnostic System Lab.,
Inc., Webster, TX, USA); the standard curve ranged between 20 and
1600 pg/ml, and intra- and inter-assay CVs were 4–8% and 8–11%
respectively. Plasma levels of tumour necrosis factor-a (TNF-a) were
determined by a commercial ELISA kit (Cat. No. 558535; BD Bioscienc-
es Pharmingen, San Diego, CA, USA; the standard curve ranged
between 5 and 500 pg/ml).
Statistical analysis
Data, expressed as mean values  SEM, were analysed by ANOVA (one-
way, neonatal treatment; or two-way, neonatal treatment and post-natal
treatment/surgery) followed by either the Fisher’s test or the
nonparametric Mann–Whitney test [19]. Morphometric data were analy-
sed by the least significant difference test [8]. P values lower than 0.05
were considered statistically different.
Results
The intact MSG rat phenotype
As expected [11], MSG rats were hypophagic (recorded on the
last experimental week and expressed as the 7-day average:
A
B C
Fig. 2 Proliferation curve of cultured
RPAT-SVF cells, obtained from CTR and
MSG rats (A). Lipid accumulation (B) and
leptin secretion (C) by SFV cells, isolated
from RPAT pads of adult CTR and MSG
intact male rats, during in vitro differentia-
tion. Values are means  SEM (one ani-
mal per group per experiment; n = 3
different experiments, with 4/5 wells per
day per experiment). *P < 0.05 versus
CTR values.
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73.54  4.41 kJ/day versus 93.41  6.22 kJ/day in CTR rats;
P < 0.05, n = 12–15 rats per group) and significantly (P < 0.05)
lighter than CTR rats; however, RPAT pad mass was higher
(P < 0.05 versus CTR) (Table 2). The peripheral concentrations
of LEP and Cort were significantly (P < 0.05 versus CTR) higher
in MSG animals (Table 2); conversely, no differences were
noticed in those of insulin, TNF-a and aldosterone (Table 2). It
is important to remark that MSG animals monitored at 30 days
of age (n = 15–17 rats per group) had already developed
hypophagia (5-day average: 40.44  2.98 kJ/day versus
50.53  3.32 kJ/day in CTR litter-mates; P < 0.05) and signifi-
cantly (P < 0.05) higher plasma levels of Cort (18.17 
2.69 nM) and LEP (2.98  0.23 ng/ml) after compared with
CTR litter-mates (Cort: 6.79  0.72 nM; and LEP: 1.08 
0.11 ng/ml). These data clearly indicate that RPAT-SVF cells from
MSG rats have been overexposed in vivo to Cort and LEP for a
minimum period of 30 days.
Figure 1 shows the histological characteristics of the RPAT
pads (representative fields) from adult intact CTR (panel A) and
MSG (panel B) male rats. Morphometric analyses indicate that
MSG rats displayed a significant (P < 0.001 versus CTR) decrease
in cell density (Fig. 1C) because of an increase in cell size
(Fig. 1D).
Precursor cell proliferation capacity
After seed (Pd 0), the proliferation capacity of RPAT-SVF cells from
either group was assessed by counting cell number every 24 hrs and
plotting those numbers throughout the proliferation period (Pd 1–Pd
9). The results indicated (Fig. 2A) a significantly (P < 0.05) enhance-
ment in the proliferation capacity of cells from the MSG group. In fact,
this has already been noticed on Pd 5 and it lasted up to the end of
the proliferation period (Pd 9). Moreover, the slopes of these curves
were as follows: 18,877  1457 and 25,670  2055 cells per day, in
CTR and MSG cell groups respectively (P < 0.05).
Precursor cell differentiation capacity
Confluent RPAT-SVF cells (seed at 100,000 cells/well, approximately)
from each group (CTR and MSG) were induced (on Dd 0) to in vitro
A B
C D
Fig. 3 Cell mRNA expression levels (in
arbitrary units: AU) of PPAR-c2 (A), C/
EBP-a (B), leptin (C) and ADIPOQ (D) dur-
ing in vitro differentiation of isolated SVF
cells isolated from RPAT pads of intact
adult CTR and MSG male rats. Values are
means  SEM (one animal per group per
experiment; n = 5/6 different experiments
with 10/12 wells per day per experiment;
nd: not detected). *P < 0.05 versus CTR
values on the same day.
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differentiation and kept in culture up to Dd 10. Then, several functions
and adipogenesis-related markers were studied in cells undergoing
differentiation.
Lipidic and endocrine functions of cells undergoing
differentiation
As intracellular lipid accumulation is a clear indicator of precursor
cell differentiation, cell lipid content was evaluated every 48 hrs
while differentiating. Although no cell lipid presence was noticed on
Dd 0 in any group, the presence of lipidic vacuoles occurred in
both cell groups on Dd 2 and later, an event corroborated after
lipid quantification (Fig. 2B). Interestingly, cell lipid content was
significantly (P < 0.05) lower in MSG than in CTR cells on all Dds.
The spontaneous release of LEP by cells in culture was also evalu-
ated, as a parameter of differentiation. As shown (Fig. 2C), medium
LEP concentration was primarily detected on Dd 4 in both groups,
although at a very low concentration in the MSG cell culture. Con-
sistently, MSG cells released significantly (P < 0.05 versus CTR
cells) lower amounts of LEP when analysed between Dds 6 and 10
(Fig. 2C).
Expression of key adipogenesis-related genes in cells
undergoing differentiation
It is accepted that PPAR-c2 is the main adipogenic factor driving the
expression of other genes involved in the final step of adipogenesis.
Although in minimal traces, cell PPAR-c2 mRNA was detected on Dd
0 in both cell groups; cell PPAR-c2 gene expression then increased
rapidly (Dd 2) after inducing differentiation (Fig. 3A). This signal
reached its highest expression level on Dd 4 in both groups; however,
cell mRNA level was several fold lower (P < 0.05 versus CTR values)
in MSG cells. Moreover, on Dd 6, expression of PPAR-c2 gene had
down-regulated in both cell groups, a pattern lasting up to Dd 10.
Notably, PPAR-c2 mRNA expression was significantly (P < 0.05)
lower in MSG than in CTR cells throughout Dds 4–10 (Fig. 3A). The
pattern of differentiating cell C/EBP-a mRNA level varied in a similar
fashion to that of PPAR-c2 gene expression, being its expression
level significantly lower in MSG than in CTR cells (Fig. 3B). Accord-
ingly to data from cell functionality, intracellular LEP mRNA appear-
ance was first detected on Dd 4 in both groups; however, its
expression level resulted significantly (P < 0.05) lower in MSG than
in CTR cells throughout Dds 6–10 (Fig. 3C). Finally, ADIPOQ gene
Fig. 4 Representative fields containing in
vitro differentiated CTR (upper left panels)
and MSG (upper right panels) adipocytes
(stained on Dd 10, magnification 10 9 ),
displaying different degrees of maturation
depending on the nucleus position: I, cen-
tral (white arrow); II, displaced from the
centre (grey arrow); and III: fully periph-
eral (black arrow). The areas marked with
arrows were enhanced to clearly show dif-
ferences in the nucleus position (white
bars: 50 lm). Percentages of in vitro dif-
ferentiated (on Dd 10) CTR and MSG
adipocytes according to their stages of
maturation are also shown (lower panel).
Values are means  SEM (one animal per
group per experiment; n = 4/5 different
experiments; data from 200/250 cells
were recorded in each experiment).
*P < 0.05 versus CTR values.
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expression in differentiating cells was significantly lower in MSG
(versus CTR) cells throughout Dds 4–10 (Fig. 3D).
Morphometry of in vitro differentiated adipocytes
Fixed cells on cover slips from Dd 10 were used to assess the per-
centage of cell differentiation and the in vitro degree of differentiation
in both groups. Data indicate that in MSG cells, a significantly lower
percentage of differentiated (lipidic vacuoles) cells was found:
62.9  2.6% and 55.6  2.9% in CTR and MSG groups respectively
(P < 0.05; n = 4/5 different experiments; counting 40–50 cells per
field from five different fields per experiment, thus summing 200–250
cells counted per experiment). In addition, the degree of maturation
attained by differentiated cells according to their nuclear position as a
parameter (Fig. 4, upper panels) indicated that MSG cells reached
impaired cell maturation. Indeed, significantly (P < 0.05 versus CTR
cells) higher and lower percentages of MSG cells in maturation stages
I and III were detected respectively (Fig. 4, lower panel).
Adipogenic and inflammatory status of RPAT
precursor cells
Given our data supporting a clear and significantly impaired differenti-
ation process of MSG RPAT-SVF cells, several adipogenesis-related
parameters in freshly isolated precursor (SVF) cells from both groups
were then evaluated. Data showing that the expression level of key
markers of precursor cell commitment (PPAR-c2 and Zfp423) was
significantly (P < 0.05) lower in MSG- than in CTR-SVF cells are
depicted in Figure 5. The latter Figure also shows that the mRNA lev-
els of two anti-adipogenic transcription factors, Pref-1 and Wnt-10b,
were three- and twofold higher, respectively, in MSG than in CTR cells
(P < 0.05). Regarding the pro-adipogenic signals measured, although
there was similar GR gene abundance in both cell groups, the MR
mRNA expression level was significantly (P < 0.05 versus CTR) lower
in MSG cells (Fig. 5).
As the expansion of the AT is often associated with an increased
inflammatory state, various RPAT-SVF cell markers of inflammation
and immune cell recruitment were evaluated. The results indicate that
CTR and MSG precursor cells express similar mRNA levels of pro-
inflammatory markers (PAI-1, TNF-a and IL-6) (Table 3). Similarly,
no differences were noticed in the SVF cell expression levels of
immune cell markers (MCP-1, F4/80 and CD11b) among cell groups
(Table 3).
Impact of endogenous GC normalization in the
MSG rat
Because of the overall impaired in vitro adipogenic capacity of RPAT-
SVF cells from the MSG rat, it was explored whether such a
dysfunction could be related to their high plasma Cort levels or not
(Experiment 2). For this purpose, experiments were conducted in nor-
mo-corticosteronaemic (CTR-SHX-P and MSG-ADX+Cort) and hyper-
corticosteronaemic (MSG-SHX+P) rats.
Rat phenotype
MSG-ADX+Cort rats displayed similar BWs to those of MSG-SHX+P
animals (Table 4). Conversely, RPAT mass in the MSG-ADX+Cort
group was significantly (P < 0.05) lower than in MSG-SHX+P rats,
thus resulting in similar values observed in CTR-SHX+P animals
(Table 4). Conversely to that observed in the circulating levels of hor-
mones in intact rats (see Table 2), the plasma Cort and LEP concen-
trations in MSG-ADX+Cort and CTR-SHX+P rats were similar, being
significantly (P < 0.05) lower than those found in MSG-SHX+P rats
(Table 4).
Fig. 5 RPAT-SVF cell mRNA concentrations of adipogenesis commit-
ment (PPAR-c2 and Zfp423), anti-adipogenic (Pref-1 and Wnt.10b) and
pro-adipogenic (GR and MR) markers. Precursor cells were isolated
from RPAT pads of adult male, CTR and MSG rats. Values are
means  SEM (n = 5/6 specimens per group). *P < 0.05 versus CTR
values.
Table 3 Pro-inflammatory and immune cell markers mRNA levels in
SFV cells from CTR and MSG animals
Marker
SVF cell mRNA (AU)
CTR MSG
PAI-1 0.997  0.116 0.745  0.115
TNF-a 1.021  0.237 0.627  0.077
IL-6 1.011  0.221 0.989  0.159
MCP-1 0.989  0.305 0.981  0.127
F 4/80 0.976  0.265 0.615  0.092
CD11b 1.032  0.341 1.139  0.252
Values are means  SEM (n = 4/5 samples per group; AU: Arbitrary
Units).
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RPAT precursor cell characteristics
Similar to that accounted in intact MSG animals (see Fig. 5), the
expression levels of precursor cell commitment (PPAR-c2 and
Zfp423) and pro-adipogenic (MR) genes were significantly
(P < 0.05 versus CTR-SHX+P) lower in the MSG-SHX+P group;
moreover, those of anti-adipogenic signals (Pref-1 and Wnt-10b
mRNAs) also were higher in MSG-SHX+P cells (P < 0.05 versus
CTR-SHX+P; Table 4). Notably, PPAR-c2 and Zfp423 mRNAs con-
centrations in precursor cells were fully corrected by normalizing
the circulating levels of GC in MSG rats (MSG-ADX+Cort; Table 4).
The enhanced precursor cell expression levels of anti-adipogeneic
genes (Pref-1 and Wnt-10b) were fully and partly, respectively
(P < 0.05), prevented by corticosterone-replacement therapy in
ADX MSG rats (Table 4). Interestingly, RPAT-SVF cells from MSG-
ADX+Cort displayed a complete (P < 0.05 versus MSG-SHX+P) res-
toration of MR mRNA expression up to values found in CTR-SHX+P
cells (Table 4), while cell GR gene abundance remained unchanged
(data not shown).
RPAT precursor cell proliferative capacity
Cort-replacement therapy in ADX MSG (MSG-ADX+Cort) rats resulted
in a significant (P < 0.05) decrease in SVF cell proliferation (n = 3/4
experiments), as analysed on Pd 5 (95,142  2320 cells) and com-
pared with MSG-SHX+P cells (118,119  4791 cells). Moreover, the
results were similar to that displayed by CTR-SHX+P cells
(94,114  3009 cells).
RPAT precursor cell adipogenic capacity
When measured on Dd 10, lipid content was significantly
(P < 0.05) higher in MSG-ADX+Cort than in MSG-SHX+P cells, and
it was similar to that of CTR-SHX+P cells (Fig. 6A). On Dd 10, the
reduced (P < 0.05 versus CTR-SHX+P cells) expression of key
marker genes (PPR-c2, C/EBP-a, LEP and ADIPOQ) in MSG-SHX+P
cells was fully corrected after normalization of plasma Cort levels
in MSG rats (MSG-ADX+Cort; Fig. 6B). The analysis of the percent-
ages of mature adipocytes (Dd 10) indicated a significantly
(P < 0.05) lower percentage in the MSG-SHX+P (57.8  3.1%)
than in the CTR-SHX+P (65.5  2.7%) group, a parameter similar
to that recorded in MSG-ADX+Cort cells (60.9  2.1%). Finally, the
analysis of the degree of maturity reached on Dd 10 in MSG-
ADX+Cort cells was characterized by lower and higher percentages
of differentiated cells in stages I and III, respectively, than those
recorded in the MSG-SHX+P cell group (Fig. 7). Interestingly, the
pattern found in MSG-ADX+Cort cells was similar to that displayed
by the CTR-SHX+P cell group (Fig. 7).
Discussion
Our study indicates that SVF cells isolated from the RPAT of the
hypertrophic obese, MSG rat possess an impaired capacity to differ-
entiate in vitro. This dysfunction seems to be mainly related to their in
vivo chronic overexposure to a GC-rich environment. The adipogenic
process in 60-day-old MSG rats was studied because, when 90 days
of age was reached, there was a deteriorated peripheral pattern of
other adipogenesis-related signals [8, 14, 17] and development of
morbid adiposity, a state characterized by deeply dysfunctional
enlarged adipocytes that release high amounts of leptin [8], with
impaired insulin sensitivity [8] and an enhanced lipogenic activity
[16]. However, we have presently addressed that hypertrophic AT
mass expansion also takes place at an earlier age.
Table 4 Bodyweight (BW), RPAT pad mass, basal circulating levels of metabolites (n = 10/12 rats per group) and RPAT cell expression
levels of pro-/anti-adipogenic genes (n = 4/5 different experiments, 4/5 replicates per experiment) in sham-operated control animals sc
implanted with placebo pellet (CTR-SHX+P) and MSG rats, either sham operated or ADX, and sc implanted with placebo (MSG-SHX+P) or
Cort (MSG-ADX+Cort) pellet
CTR-SHX+P MSG-SHX+P MSG-ADX+Cort
BW (g) 278.61  13.93 211.79  11.78* 216.57  8.66*
RPAT Mass (g/100 g BW) 2.53  0.18 5.62.04  0.56* 3.67  0.38†
Corticosterone (nM) 20.21  4.09 41.86  8.86* 19.45  2.14†
LEP (ng/ml) 4.82  0.61 13.28  2.03* 3.88  0.45†
RPAT-SVF Cell PPAR-c2 (AU) 1.01  0.11 0.58  0.05* 0.88  0.07†
RPAT-SVF Cell Zfp423 (AU) 0.98  0.08 0.53  0.12* 0.91  0.14†
RPAT-SVF Cell Pref-1 (AU) 0.99  0.09 2.81  0.16* 1.37  0.17†
RPAT-SVF Cell Wnt-10b (AU) 1.02  0.15 2.51  0.44* 1.62  0.29
RPAT-SVF Cell MR (AU) 1.03  0.19 0.55  0.15* 1.12  0.09†
Values are the mean  SEM.
*P < 0.05 versus CTR-SHX+P values.
†P < 0.05 versus MSG-SHX+P values.
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Zfp423 is a signal that regulates AT precursor cell commitment
and, in turn, PPAR-c2 expression [1]; moreover, Zfp423 acts as a
co-activator of Smad proteins and amplifies the pro-adipogenic and
PPAR-c2-inducing activities [22]. In this regard, our data indicate
that RPAT precursors isolated from MSG rats under-expressed
Zpf423 and PPAR-c2 genes, thus suggesting a lower abundance of
AT-committed cells [1] in their RPAT SVF. The MSG phenotype car-
ries high peripheral Cort levels and their RPAT-SVF cells display
both enhanced proliferation capacity and reduced MR mRNA levels.
Given that GCs are inhibitors of cell proliferation [23], these data
could suggest that a state of GC resistance has been established at
the precursor cell level. Nevertheless, a high leptinaemia-dependent
effect on SVF cell proliferation should not be discarded [24]. Indeed,
the diminished PPAR-c2 gene expression in differentiating MSG cells
could partly be related to their high leptinaemia. In fact, it has been
shown that AT precursor cells from db/db mice, transgenic for ob-
Rb [25], overexpress Pref-1 mRNA, as occurred in MSG rats; inter-
estingly, those mice display retarded adipogenesis [25]. As previ-
ously described [26], the adrenal leptin resistance in MSG rats can
be overridden by bilateral ADX-reduced leptinaemia. Therefore, hy-
perleptinaemia could be another direct/indirect factor regulating
MSG RPAT-SVF cell expression of Pref-1/Wnt [25] and thus adipo-
genesis [27].
A bi-directional link between obesity and inflammation is now
accepted [28, 29]. As known, AT inflammation contributes to the
development of several deleterious metabolic effects in obesity and
later cooperates with the development of insulin resistance [30]. TNF-
a and IL-6, two well-known pro-inflammatory cytokines, affect insulin
action and promote insulin resistance [31–33]. In turn, this local (AT)
pro-inflammatory environment induces the recruitment of immune
cells. However, the expression of several cell markers of inflammation
and immune cell recruitment in RPAT-SVF cells remain unaltered in
MSG rats; moreover, similar results in RPAT pads from these rats
were also found (data not shown). It is accepted that the activation of
GR receptors in AT inhibits the pro-inflammatory response, while MR
activation induces an anti-inflammatory activity [34, 35]. It is highly
probable that the altered balance between GR and MR in MSG RPAT-
SVF cells could be, at least partially, responsible for the lack of an
enhanced pro-inflammatory activity in their hypertrophic RPAT pads.
There are published data tallying with our findings with reference to a
lack of an installed inflammatory state in different obese phenotypes.
As example, it has been described that DXM treatment in high-fat
A
B
Fig. 6 Cell lipid content (A) and adipogen-
esis-related gene expression (B) in differ-
ent groups (CTR-SHX+P, MSG-SHX+P
and MSG-ADX+Cort rats) evaluated on dif-
ferentiation 10. Values are means  SEM
(one animal per group per experiment;
n = 4/5 different experiments, with 5
wells per experiment). *P < 0.05 versus
CTR-SHX+P values; +P < 0.05 versus
MSG-ADX+Cort values.
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diet-induced obese mice inhibits their immune response [36] and that
the adult MSG male rat did secrete less TNF-a than normal rats dur-
ing acute endotoxaemia [17]. Moreover, human patients with Cush-
ing’s syndrome display increased adiposity but not any chronic
inflammatory state [37, 38].
As seen in other obese phenotypes [39, 40], the impaired differ-
entiation capacity of MSG RPAT-SVF cells could result from changes
in pre-adipocyte sensitivity to inducers of differentiation [39]. Indeed,
DXM stimulation is a crucial signal activating precursor cell PPAR-c2
mRNA expression [41], a key cell-marker triggering final steps of the
differentiation process. It was found, on the normal peak day (Dd 4 in
CTR cells) of cell PPAR-c2 gene abundance, that this cell marker was
very low in the MSG cell population. Interestingly, through differentia-
tion of MSG precursor cells, their metabolic (lipidic) functionality first
appeared, as in normal cells, on Dd 2 and coincidentally with PPAR-
c2 expression. However, MSG cells resulted metabolically dysfunc-
tional, and later (Dd 4), the malfunction accounted for their endocrine
function (leptin gene abundance/leptin secretion). These dysfunctions
could be indicative for a disrupted final sequence of events up to
reach the mature adipocyte phenotype. Nevertheless, the departing
reduced MSG RPAT precursor cell MR expression seems to be the
first crucial step affected throughout adipogenesis.
Our data that indicate a clear relationship between low MSG
RPAT-SVF cell MR expression and impaired cell differentiation fully
agree with previous reports. Indeed, when confluent MR-expressing
3T3-L1 cells were induced to differentiate in vitro and then cultured
with aldosterone alone, cells enhanced their PPAR-c2 mRNA expres-
sion, accumulated lipid and produced adipokines [2]. Interestingly,
the authors showed that these events were fully prevented by co-
incubating cells with spironolactone or by knocking-down cell MR
[2], but not by silencing GR [2]. In line with these observations, a
mouse pre-adipocyte cell line lacking MR overexpresses Pref-1,
despite no changes in Pref-1 when these cells were knockout for GR
[35]. However, an appropriate cell balance in MR/GRs determines
both the phenotype of mature adipocytes [35] and the regional distri-
bution of them [42]. All together, this evidence highlights a pivotal
role of MR in corticoid-induced adipogenesis [2, 35, 42, 43].
It was previously observed that correcting GC excess in MSG rats
[8, 14], a full reversion of several metabolic and endocrine dysfunc-
tions accounted, thus clearly indicating that GC overproduction plays
a key role not only in the development but also in the maintenance of
the MSG rat phenotype. GC is a potent adipogenic factor [3, 4]
because of its inhibitory activity on precursor cell Pref-1 [44]. AT pre-
cursor cell differentiation requires the suppression/repression of
Pref-1/Wnt-10b [3, 4]. Although a clear suppressive effect of GC on
precursor cell Pref-1 is accepted [3, 4], conversely, little is known
regarding any GC regulatory activity on Wnt functionality, namely at
earlier steps of adipogenesis. In this respect, MR/GRs interact with
elements of the Wnt signalling pathway [45], and its activation
favours precursor cell differentiation [46]. However, it is also
accepted that enhanced Wnt-10b signalling inhibits adipogenesis
[47]. During cell trans-differentiation, a transient suppression of Wnt
Fig. 7 Representative fields containing in
vitro differentiated adipocytes from differ-
ent groups (CTR-SHX+P, MSG-SHX+P
and MSG-ADX+Cort rats; upper panels).
Cells were stained on Dd 10, magnifica-
tion 10 9 and display different degrees
of maturation depending on the nucleus
position (for more details, see legend in
Fig. 4): I, central; II, displaced from the
centre; and III: fully peripheral (white bars:
50 lm). Percentages of in vitro differenti-
ated (on Dd 10) CTR-SHX+P, MSG-
SHX+P and MSG-ADX+Cort adipocytes
according to their stages of maturation
are also shown (lower panel). Values are
means  SEM (one animal per group per
experiment; n = 4/5 different experiments;
data from 200/250 cells were recorded in
each experiment). *P < 0.05 versus CTR-
SHX+P values; +P < 0.05 versus MSG-
ADX+Cort values.
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gene expression/signalling is required, and it has been established
that an excess of GC is able to inhibit this signal [48]. Reduced MSG
RPAT-SVF cell MR expression could be responsible for a low corti-
coid inhibitory effect on Pref-1/Wnt-10b, thus resulting in an overall
impaired adipogenic process. We also addressed that this cell dys-
function is, at least partly, dependent on a rich corticosterone milieu.
Indeed, our experiments with RPAT-SVF cells from MSG rats devoid
of chronic high peripheral GC levels indicated that cells recovered
normal proliferation and Zfp423/PPAR-c2 gene expression and
balanced mRNA expression levels of anti-(Pref-1/Wnt-10b) and
pro-(MR) adipogenic signals. Moreover, fully differentiated MSG-
ADX+Cort adipocytes accumulated lipid, expressed key adipogenic-
marker genes and displayed a degree of maturity similar to that
occurred in CTR (normal) cells.
In conclusion, an impaired adipogenic process taking place in
the adult MSG rat was addressed, a dysfunction dependent on the
endogenous GC-rich environment. Such an impaired process could
be inducing to an unhealthy [18, 49], hypertrophic AT mass
expansion. The latter could be triggered by precursor cells overex-
pressing Pref-1, as found in MSG rats and other human obese
phenotypes [50]. The study further supports a MSG RPAT-SVF
cell mis-programming, a failure related to a GC-dependent basis
rather than to any epigenetic modification. This highlights the clin-
ical relevance of correcting corticoadrenal hyperactivity to counter-
act AT-induced metabolic-endocrine dysfunctions in Cushing’s
syndrome and other hypertrophic obese phenotypes [10, 18, 49,
50].
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